Current Role of Liquid Biopsy in NSCLC
Podcast | English | 44 Min
Image For Activity Cover
No Credit Offered
Over the past few years, the use of liquid biopsy has improved the ability to detect biomarkers for non-small cell lung cancer. In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the current state of liquid biopsies with Dr. David Gandara, Professor of Medicine and Director of Thoracic Oncology at the University of California, Davis; Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at the University of Pennsylvania; and Dr. Christian Rolfo, Professor of Medicine at Mount Sinai in New York City and the Associate Director for Clinical Research in the Center for Thoracic Oncology at the Tisch Cancer Institute.

Podcast Hosts:

  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA 

Podcast Guests: 

  • Charu Aggarwal, MD, MPH, Leslye M. Heisler Associate Professor for Lung Cancer Excellence, University of Pennsylvania, Philadelphia, PA, USA
  • David Gandara, MD, Chief Medical Officer, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA
  • Christian Rolfo, MD, PhD, MBA, Dr.hc., Professor and Assoc. Director for Clinical Research, Center for Thoracic Oncology/Tisch Cancer Institute Icahn School of Medicine at Mount Sinai Mount Sinai Health System, New York, NY, USA
Powered By